BLPH - Bellerophon Therapeutics EPS beats by $0.21 August, 05 2020 08:41 AM Bellerophon Therapeutics Inc. Bellerophon Therapeutics (NASDAQ:BLPH): Q2 GAAP EPS of -$0.51 beats by $0.21.Cash and cash equivalents of $59.3M.Press ReleaseMore news on: Bellerophon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,